**Core Concept:**
Anti-D immunoglobulin is a specific type of immunoglobulin (IgG) used to prevent Rh isoimmunization in pregnant women with Rh-negative blood type. It binds to Rh-positive red blood cells, preventing their entry into the fetus and preventing the production of Rh-antibodies by the mother's immune system.

**Why the Correct Answer is Right:**
The correct answer is D due to the following reasons:

* Anti-D Ig is a specific immunoglobulin that binds to Rh-positive red blood cells, preventing their entry into the fetus.
* This prevents the Rh-positive cells from stimulating the mother's immune system to produce Rh-antibodies.
* Anti-D Ig is given to pregnant women with Rh-negative blood type to prevent Rh isoimmunization.

**Why Each Wrong Option is Incorrect:**
A. This option is incorrect because anti-D Ig is specific to Rh-positive cells and does not target other types of immunoglobulins or antibodies.
B. This answer is wrong because the timing of administration does not affect the effectiveness of anti-D Ig in preventing Rh isoimmunization.
C. This answer is incorrect because the route of administration (intramuscular) does not impact the biological action of anti-D Ig, which directly binds to Rh-positive red blood cells.

**Clinical Pearl:**
In clinical practice, anti-D Ig is administered during the 28th week of pregnancy or immediately after a Rh-positive blood transfusion. It is crucial to ensure proper administration timing and route to effectively prevent Rh isoimmunization in Rh-negative pregnant women.

**Correct Answer:**
Correct Answer: D (Intravenous administration)

**Why Anti-D Ig is given:**
Anti-D Ig is given to pregnant women with Rh-negative blood type to prevent Rh isoimmunization, which can lead to severe hemolytic disease of the fetus and newborn (HDFN) in subsequent pregnancies. By neutralizing Rh-positive red blood cells, anti-D Ig helps to avoid the production of Rh-antibodies in the mother's immune system.

**Why Anti-D Ig is given at particular timings:**
1. **28 weeks gestation:** Administering anti-D Ig during the 28th week of pregnancy ensures that the drug reaches the target cells (Rh-positive red blood cells) before they enter the mother's circulation and bind to her immune system, triggering the production of Rh-antibodies.
2. **After Rh-positive blood transfusion:** Administering anti-D Ig immediately after a Rh-positive blood transfusion ensures that the drug neutralizes the transfused Rh-positive red blood cells before they are recognized by the mother's immune system, preventing the production of Rh-antibodies.

**Why intravenous administration is preferred:**
The intravenous administration of anti-D Ig allows for a more rapid uptake into the maternal circulation, ensuring efficient neutralization of Rh-positive red blood cells and preventing the production of Rh-antibodies in the mother's immune system. Intravenous administration is not only faster, but